The FDA has issued premarket approval to Bausch + Lomb for its enVista toric MX60T hydrophobic acrylic IOL for astigmatism correction, according to a press release.
Featuring a one-piece aberration-free aspheric optic with a fenestrated, step-vaulted modified C-loop haptic design, the lens demonstrated 5° or less of absolute rotation in 100% of subjects in a prospective study, the release said.
“Building on the proven features and benefits of the enVista family of IOLs, MX60T represents another innovation in the continued expansion of this lens platform,” Chuck Hess, vice
Uncategorized